TNYA Tenaya Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TNYA

Price (delayed)

$0.6613

Market cap

$148.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.52

Enterprise value

$74.15M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 27
Highlights
The debt has dropped by 68% year-on-year and by 61% since the previous quarter
The EPS has increased by 45% year-on-year but it has declined by 13% since the previous quarter
TNYA's equity is down by 35% from the previous quarter and by 30% YoY
The quick ratio is down by 27% YoY and by 24% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://www.tenayatherapeutics.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of TNYA

TNYA stock price

How has the Tenaya Therapeutics stock price performed over time
Intraday
-3.06%
1 week
0.55%
1 month
-5.16%
1 year
-50.28%
YTD
-7.06%
QTD
-10.53%

Financial performance

How have Tenaya Therapeutics's revenue and profit performed over time
Revenue
$1.34M
Gross profit
$1.34M
Operating income
-$105.86M
Net income
-$103.12M
Gross margin
100%
Net margin
-7,724%
The net margin has surged by 79% since the previous quarter
TNYA's operating margin has surged by 79% since the previous quarter
The net income has declined by 24% since the previous quarter and by 3.5% year-on-year
The operating income has declined by 23% since the previous quarter and by 2.8% year-on-year

Price vs fundamentals

How does TNYA's price correlate with its fundamentals

Growth

What is Tenaya Therapeutics's growth rate over time

Valuation

What is Tenaya Therapeutics stock price valuation
P/E
N/A
P/B
2.07
P/S
107.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
55.54
The EPS has increased by 45% year-on-year but it has declined by 13% since the previous quarter
TNYA's equity is down by 35% from the previous quarter and by 30% YoY
TNYA's P/B is 33% above its 5-year quarterly average of 1.6 and 7% above its last 4 quarters average of 2.0

Efficiency

How efficient is Tenaya Therapeutics business performance
TNYA's ROIC has shrunk by 197% YoY and by 78% QoQ
The return on sales has surged by 79% since the previous quarter
Tenaya Therapeutics's return on equity has decreased by 34% QoQ and by 15% YoY
The ROA has contracted by 32% from the previous quarter and by 13% YoY

Dividends

What is TNYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNYA.

Financial health

How did Tenaya Therapeutics financials performed over time
Tenaya Therapeutics's total assets has decreased by 31% from the previous quarter and by 23% YoY
The quick ratio is down by 27% YoY and by 24% QoQ
The debt is 94% smaller than the equity
The debt has dropped by 68% year-on-year and by 61% since the previous quarter
TNYA's debt to equity has dropped by 50% year-on-year and by 40% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.